| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TGTX | Common Stock | Award | $0 | +1M | +8.3% | $0.00 | 13.1M | Jan 6, 2024 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Reflects a grant of restricted shares, which will vest and become non-forfeitable based on the Company's total shareholder return relative to the Nasdaq Biotechnology Index over a one-year to five-year period, provided that the Reporting Person remains an employee, director and/or consultant of the Company through each vesting date. |
| F2 | Includes shares of restricted Common Stock, which vest over various time periods. |